loading page

Application of Protek Duo RD™ Dual Lumen Cannula Without Anticoagulation Use in Patients Successfully Bridged to Lung Transplantation
  • +5
  • Michael Markovich,
  • Jessia HarrisOrcid,
  • Sanna Mohammad,
  • April Grant MD,
  • Vicente Orozco Sevilla,
  • Rodrigo Vianna MD, PhD,
  • Matthias Loebe,
  • Ali Ghodsizad
Michael Markovich
Jackson Memorial Hospital
Author Profile
Jessia Harris
Orcid
Jackson Memorial Hospital
Author Profile
Sanna Mohammad
Jackson Memorial Hospital
Author Profile
April Grant MD
Author Profile
Vicente Orozco Sevilla
Author Profile
Rodrigo Vianna MD, PhD
University of Miami Miller School of Medicine
Author Profile
Matthias Loebe
Jackson Memorial Hospital
Author Profile
Ali Ghodsizad
University of Miami
Author Profile

Peer review status:IN REVISION

03 Jun 2020Submitted to Journal of Cardiac Surgery
04 Jun 2020Assigned to Editor
04 Jun 2020Submission Checks Completed
15 Jun 2020Reviewer(s) Assigned
29 Jun 2020Review(s) Completed, Editorial Evaluation Pending
08 Jul 2020Editorial Decision: Revise Major

Abstract

Respiratory failure is a common cause of death. It is proven that Extracorporeal Membrane Oxygenation (ECMO) cannulation is successful in bridging patients to lung transplantation. Here we report on a 51-year-old patient with COPD who was bridged successfully to lung transplantation using venous-venous ECMO with a Protek Duo RD™ dual lumen cannula; which contributed to our success in bridging to transplant without the need for anticoagulation. Here we confirm that the clinical application use of the cannula without IV Heparin use is safe and feasible.